Table 2.
Doses and duration of TXA2 infusion until target mean PAP.
| RDN group (N = 4) | P | Sham group (N = 4) | P | P value between RDN and sham groups before denervation or balloon inflation | P value between RDN and sham groups after denervation or balloon inflation | |||
|---|---|---|---|---|---|---|---|---|
| Before RDN | After RDN | Before sham | After sham | |||||
| TXA2 dose, mcg/min (mean ± SD; median [IQR]) | 0.1 ± 0.02 0.11 [0.08; 0.12] |
0.09 ± 0.01 0.1 [0.08; 0.1] |
0.58 | 0.12 ± 0.03 0.12 [0.09; 0.13] |
0.11 ± 0.04 0.875 [0.07; 0.13] |
0.59 | 0.56 | 1.0 |
| TXA2 dose, mcg (mean ± SD; median [IQR]) | 23.9 ± 5.1 25.1 [20.3; 27.5] |
21.5 ± 2.6 22.2 [19.9; 23.2] |
0.46 | 22.6 ± 6.2 22.84 [18.4; 26.8] |
20.5 ± 8.4 16.95 [15.2; 25.9] |
0.59 | 0.66 | 0.47 |
| Time until mPAP reaches 40 mmHg (mean ± SD; median [IQR]) | 17.5 ± 2.9 17.5 [15; 20] |
17.2 ± 3.2 17.5 [14.5; 20] |
0.79 | 16.7 ± 6.7 19.0 [12.5; 21] |
15.7 ± 7.1 13.5 [11; 20.5] |
0.71 | 0.88 | 0.56 |
IQR: interquartile range; mPAP: medium pulmonary artery pressure; PAP: pulmonary artery pressure; RDN: renal denervation; SD: standard deviation; TXA2: thromboxane A2.